Malathion


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000067877 Autism Spectrum Disorder PMID:30894343
MESH:D000382 Agricultural Workers' Diseases PMID:11874814; PMID:17119214; PMID:17932376; PMID:17975796; PMID:19541724; PMID:20730623; PMID:20818537; PMID:23171882; PMID:24064777; PMID:24906048
MESH:D001145 Arrhythmias, Cardiac PMID:2124029
MESH:D001249 Asthma PMID:17932376; PMID:19541724
MESH:D001943 Breast Neoplasms PMID:12762645
MESH:D002057 Burns, Chemical PMID:27214522
MESH:D003110 Colonic Neoplasms PMID:20730623
MESH:D003638 Deafness PMID:672367
MESH:D003866 Depressive Disorder PMID:17327255; PMID:19429114; PMID:24906048
MESH:D003924 Diabetes Mellitus, Type 2 PMID:20233601
MESH:D005832 Genital Diseases, Male PMID:32495713
MESH:D005911 Gliosis PMID:28987951
MESH:D006529 Hepatomegaly PMID:24810974; PMID:25180440; PMID:36370973
MESH:D006943 Hyperglycemia PMID:25180440
MESH:D006946 Hyperinsulinism PMID:25180440
MESH:D007037 Hypothyroidism PMID:24064777
MESH:D007153 Immunologic Deficiency Syndromes PMID:6857660
MESH:D007248 Infertility, Male PMID:30409133
MESH:D007249 Inflammation PMID:24810974
MESH:D007333 Insulin Resistance PMID:25449180; PMID:36370973
MESH:D007964 Leukocytosis PMID:27214522
MESH:D007970 Leukopenia PMID:27214522
MESH:D008113 Liver Neoplasms PMID:20143881
MESH:D008228 Lymphoma, Non-Hodgkin PMID:11700263
MESH:D008325 Mammary Neoplasms, Experimental PMID:11401758
MESH:D009336 Necrosis PMID:15036745; PMID:19607909
MESH:D009422 Nervous System Diseases PMID:1665979
MESH:D009503 Neutropenia PMID:27214522
MESH:D010523 Peripheral Nervous System Diseases PMID:18780003
MESH:D011041 Poisoning PMID:1665979; PMID:2124029; PMID:28456311; PMID:31521933; PMID:3424038
MESH:D011115 Polyneuropathies PMID:2124029
MESH:D011471 Prostatic Neoplasms PMID:23171882; PMID:23593118
MESH:D012128 Respiratory Distress Syndrome PMID:2124029
MESH:D012133 Respiratory Paralysis PMID:3424038
MESH:D012135 Respiratory Sounds PMID:11874814; PMID:17119214; PMID:27384423
MESH:D012140 Respiratory Tract Diseases PMID:17119214
MESH:D012220 Rhinitis PMID:20818537
MESH:D013733 Testicular Diseases PMID:28987951
MESH:D013964 Thyroid Neoplasms PMID:26150671
MESH:D015228 Hypertriglyceridemia PMID:20233601
MESH:D018149 Glucose Intolerance PMID:36370973
MESH:D018908 Muscle Weakness PMID:23774768
MESH:D020258 Neurotoxicity Syndromes PMID:15081274
MESH:D029481 Bronchitis, Chronic PMID:17975796
MESH:D050171 Dyslipidemias PMID:36370973
MESH:D055371 Acute Lung Injury PMID:33510276; PMID:34262720
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:21628957; PMID:22331495; PMID:24810974; PMID:28987951; PMID:33510276; PMID:36345843; PMID:36370973
MESH:D058186 Acute Kidney Injury PMID:28987951; PMID:33510276
MESH:D062025 Organophosphate Poisoning PMID:19949736; PMID:6857660; PMID:9080632
MESH:D065631 Rhinitis, Allergic PMID:27384423

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.